These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7490170)

  • 21. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN; Pfaller MA
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of bacterial isolates to cefepime in comparison to other broad spectrum antimicrobial agents at a tertiary care center in Lebanon.
    Kanj SS; Chedid M; Araj GF
    J Med Liban; 2001; 49(1):13-7. PubMed ID: 11910959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of resistance patterns of gram-negative rods from personal clinical materials].
    Kedzierska J; Dolezal M; Kachlik P
    Med Dosw Mikrobiol; 1999; 51(1-2):113-22. PubMed ID: 10865437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.
    Peleg AY; Franklin C; Bell JM; Spelman DW
    Clin Infect Dis; 2005 Dec; 41(11):1549-56. PubMed ID: 16267725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
    Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3616-22. PubMed ID: 11709353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000.
    Shannon KP; French GL
    J Antimicrob Chemother; 2004 May; 53(5):818-25. PubMed ID: 15028663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
    Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
    Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Resistance to beta-lactams].
    Williams D
    Antibiot Khimioter; 1997; 42(10):5-9. PubMed ID: 9412405
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of the cell wall permeability of Klebsiella spp. on beta-lactam antibiotic resistance].
    Prokopenko VM; Zatonskaia VM
    Antibiotiki; 1983 Dec; 28(12):902-4. PubMed ID: 6559051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of bacterial resistance to quinolones.
    Acar JF; O'Brien TF; Goldstein FW; Jones RN
    Drugs; 1993; 45 Suppl 3():24-8. PubMed ID: 7689447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistance to antibiotics caused by decrease of the permeability in gram-negative bacteria].
    Nguyen Van JC; Gutmann L
    Presse Med; 1994 Mar; 23(11):522, 527-31. PubMed ID: 8022741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and control of resistance to the quinolones.
    Vellend H
    Clin Invest Med; 1989 Feb; 12(1):74-5. PubMed ID: 2920485
    [No Abstract]   [Full Text] [Related]  

  • 34. Concept, design, and preclinical evaluation of quinolonyl lactam antibacterials.
    Hershberger PM; Demuth TP
    Adv Exp Med Biol; 1998; 456():239-67. PubMed ID: 10549372
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evolution of the intestinal flora in patients under preventive treatment with cephalosporins].
    Lucain C; Ducel G; Piffaretti JC
    Schweiz Med Wochenschr; 1982 Jun; 112(23):817-23. PubMed ID: 7048519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of quinolones.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():197-9. PubMed ID: 8549302
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial resistance: a class effect?
    Prieto J; Calvo A; Gómez-Lus ML
    J Antimicrob Chemother; 2002 Dec; 50 Suppl S2():7-12. PubMed ID: 12556428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antimicrobials.
    Stone JW; Davies AJ
    Br J Hosp Med; 1986 Aug; 36(2):119-23. PubMed ID: 3638147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Routine isolation of mutants resistant to beta-lactams among gram-negative microorganisms].
    Giacometti A; Branchesi P; Corbelli G; Fiorentini A; Petroni S; Scalise G
    G Ital Chemioter; 1991; 38(1-3):149-50. PubMed ID: 1365572
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiology of bacterial infection during management of open leg fractures.
    Carsenti-Etesse H; Doyon F; Desplaces N; Gagey O; Tancrède C; Pradier C; Dunais B; Dellamonica P
    Eur J Clin Microbiol Infect Dis; 1999 May; 18(5):315-23. PubMed ID: 10421037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.